| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.85 | 0.0005 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.42 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.29 | 0.3 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.26 | 4e-07 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.24 | 0.4 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.09 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.09 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |